Financials TATA Health International Holdings Limited

Equities

1255

KYG7998M1033

Apparel & Accessories Retailers

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
0.3 HKD -.--% Intraday chart for TATA Health International Holdings Limited -.--% -6.25%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 656 502.9 774.7 597.1 386.1 213.7
Enterprise Value (EV) 1 774.6 544 841.3 654.4 391.8 231.1
P/E ratio -15.1 x -285 x -12.7 x -3.93 x -6.07 x 22.2 x
Yield - - - - - -
Capitalization / Revenue 1.36 x 1.4 x 2.27 x 3.84 x 2.4 x 1.48 x
EV / Revenue 1.6 x 1.52 x 2.46 x 4.21 x 2.43 x 1.6 x
EV / EBITDA -22.6 x 133 x -25.7 x -4.47 x -6.9 x -7.98 x
EV / FCF 11 x 121 x 14.8 x 16.8 x 7.95 x -14.8 x
FCF Yield 9.09% 0.82% 6.76% 5.94% 12.6% -6.75%
Price to Book 3.95 x 2.29 x 4.82 x 59.2 x 16.8 x 6.35 x
Nbr of stocks (in thousands) 200,000 214,000 214,000 214,000 242,845 242,845
Reference price 2 3.280 2.350 3.620 2.790 1.590 0.8800
Announcement Date 4/18/18 4/25/19 4/28/20 4/29/21 4/28/22 4/26/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 483.7 358 341.8 155.4 160.9 144.6
EBITDA 1 -34.2 4.077 -32.7 -146.3 -56.79 -28.95
EBIT 1 -42.27 0.379 -37.06 -148.9 -58.2 -30.06
Operating Margin -8.74% 0.11% -10.84% -95.82% -36.17% -20.79%
Earnings before Tax (EBT) 1 -42.93 6.583 -67.45 -172.7 -69.14 4.104
Net income 1 -43.44 -1.749 -60.92 -151.9 -60.76 9.613
Net margin -8.98% -0.49% -17.83% -97.75% -37.76% 6.65%
EPS 2 -0.2172 -0.008260 -0.2847 -0.7097 -0.2619 0.0396
Free Cash Flow 1 70.43 4.483 56.83 38.9 49.3 -15.6
FCF margin 14.56% 1.25% 16.63% 25.04% 30.64% -10.79%
FCF Conversion (EBITDA) - 109.96% - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/18/18 4/25/19 4/28/20 4/29/21 4/28/22 4/26/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 119 41.1 66.6 57.4 5.65 17.4
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -3.467 x 10.09 x -2.038 x -0.3921 x -0.0994 x -0.6005 x
Free Cash Flow 1 70.4 4.48 56.8 38.9 49.3 -15.6
ROE (net income / shareholders' equity) -23.2% 3.02% -32.7% -189% -585% 19.7%
ROA (Net income/ Total Assets) -6.83% 0.07% -6.94% -38.7% -21.5% -10.6%
Assets 1 635.8 -2,524 877.5 392.5 282.5 -90.28
Book Value Per Share 2 0.8300 1.030 0.7500 0.0500 0.0900 0.1400
Cash Flow per Share 2 0.1200 0.1300 0.2200 0.1300 0.1100 0.1400
Capex 1 2.26 1.7 2.77 3.09 1.08 0.89
Capex / Sales 0.47% 0.48% 0.81% 1.99% 0.67% 0.61%
Announcement Date 4/18/18 4/25/19 4/28/20 4/29/21 4/28/22 4/26/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 1255 Stock
  4. Financials TATA Health International Holdings Limited